The following articles (labelled with PubMed ID or TBD) are for your review| PMID | Article Title | Published | Deposition |
|---|
| 31158743 |
Caffeic acid phenethyl ester (CAPE)-derivatives act as selective inhibitors of acetylcholinesterase. |
01-SEP-2019 |
24-FEB-2021 |
| 30388464 |
Computer-aided design, synthesis and biological characterization of novel inhibitors for PKMYT1. |
01-JAN-2019 |
19-FEB-2021 |
| 9461567 |
Evidence for the absolute conformational specificity of the intestinal H+/peptide symporter, PEPT1. |
13-FEB-1998 |
30-AUG-2020 |
| 11284702 |
A novel inhibitor of the mammalian peptide transporter PEPT1. |
10-APR-2001 |
30-AUG-2020 |
| 30220607 |
Unexpected AChE inhibitory activity of (2E)?,?-unsaturated fatty acids. |
01-NOV-2018 |
18-AUG-2020 |
| 29941193 |
Identification of PKMYT1 inhibitors by screening the GSK published protein kinase inhibitor set I and II. |
07-AUG-2018 |
17-AUG-2020 |
| 29494161 |
Potent and Selective Inhibitors of Human Sirtuin 5. |
22-MAR-2018 |
15-DEC-2019 |
| 28478927 |
Discovery of novel substituted benzo-anellated 4-benzylamino pyrrolopyrimidines as dual EGFR and VEGFR2 inhibitors. |
15-JUN-2017 |
15-OCT-2019 |
| 27936444 |
Amino derivatives of platanic acid act as selective and potent inhibitors of butyrylcholinesterase. |
27-JAN-2017 |
18-JUN-2019 |
| 27689726 |
Repurposing N,N'-bis-(arylamidino)-1,4-piperazinedicarboxamidines: An unexpected class of potent inhibitors of cholinesterases. |
05-JAN-2017 |
07-SEP-2018 |
| 26048803 |
Discovery of substituted 1,4-dihydroquinolines as novel promising class of P-glycoprotein inhibitors: First structure-activity relationships and bioanalytical studies. |
13-JUN-2015 |
14-NOV-2016 |
| 24650640 |
Discovery of 4-anilinoa-carbolines as novel Brk inhibitors. |
07-APR-2014 |
06-FEB-2015 |
| 22770610 |
Evaluation of potential Myt1 kinase inhibitors by TR-FRET based binding assay. |
11-MAR-2013 |
24-SEP-2013 |
| 23039927 |
Multitargeted drug development: Discovery and profiling of dihydroxy substituted 1-aza-9-oxafluorenes as lead compounds targeting Alzheimer disease relevant kinases. |
22-OCT-2012 |
17-MAY-2013 |
| 15974593 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1. |
24-JUN-2005 |
03-DEC-2012 |
| 14667225 |
Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1. |
11-DEC-2003 |
30-NOV-2012 |
| 12593668 |
Evaluation of the first cytostatically active 1-aza-9-oxafluorenes as novel selective CDK1 inhibitors with P-glycoprotein modulating properties. |
20-FEB-2003 |
30-NOV-2012 |
| 22189141 |
In vitro and in silico studies on substrate recognition and acceptance of human PKMYT1, a Cdk1 inhibitory kinase. |
13-JAN-2012 |
22-JUL-2012 |
| 21955456 |
Three-dimensional quantitative structure-activity relationship analyses of substrates of the human proton-coupled amino acid transporter 1 (hPAT1). |
17-OCT-2011 |
21-JUL-2012 |
| 21035334 |
Discovery and selectivity-profiling of 4-benzylamino 1-aza-9-oxafluorene derivatives as lead structures for IGF-1R inhibitors. |
08-NOV-2010 |
14-JUN-2011 |
| 10579836 |
Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors. |
17-DEC-1999 |
10-NOV-2009 |
| 16821788 |
Structural requirements for the substrates of the H+/peptide cotransporter PEPT2 determined by three-dimensional quantitative structure-activity relationship analysis. |
06-JUL-2006 |
10-NOV-2009 |
| 16640345 |
Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells. |
27-APR-2006 |
10-NOV-2009 |
| 15664865 |
Novel CDK inhibition profiles of structurally varied 1-aza-9-oxafluorenes. |
01-FEB-2005 |
30-JAN-2006 |
Search and Browse
